vs
Side-by-side financial comparison of Agilent Technologies (A) and LEVI STRAUSS & CO (LEVI). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.8B, roughly 1.0× LEVI STRAUSS & CO). Agilent Technologies runs the higher net margin — 17.0% vs 8.9%, a 8.0% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs -4.0%). LEVI STRAUSS & CO produced more free cash flow last quarter ($215.7M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 6.5%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Levi Strauss & Co. is an American clothing company known worldwide for its Levi's brand of denim jeans. It was founded in May 1853 when German-Jewish immigrant Levi Strauss moved from Buttenheim, Bavaria, to San Francisco, California, to open a West Coast branch of his brothers' New York dry goods business. Although the corporation is registered in Delaware, the company's corporate headquarters is located in Levi's Plaza in San Francisco.
A vs LEVI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.8B |
| Net Profit | $305.0M | $158.0M |
| Gross Margin | 52.6% | 60.8% |
| Operating Margin | 19.6% | 11.9% |
| Net Margin | 17.0% | 8.9% |
| Revenue YoY | 7.0% | -4.0% |
| Net Profit YoY | -4.1% | -13.4% |
| EPS (diluted) | $1.07 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.8B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.7B | $1.8B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.4B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $158.0M | ||
| Q3 25 | $336.0M | $218.1M | ||
| Q2 25 | $215.0M | $67.0M | ||
| Q1 25 | $318.0M | $135.0M | ||
| Q4 24 | $351.0M | $182.5M | ||
| Q3 24 | $282.0M | $20.7M | ||
| Q2 24 | $308.0M | $18.0M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 60.8% | ||
| Q3 25 | 51.1% | 61.7% | ||
| Q2 25 | 51.9% | 62.6% | ||
| Q1 25 | 53.5% | 62.1% | ||
| Q4 24 | 53.9% | 61.3% | ||
| Q3 24 | 54.2% | 60.0% | ||
| Q2 24 | 54.4% | 60.5% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 11.9% | ||
| Q3 25 | 20.7% | 10.8% | ||
| Q2 25 | 18.0% | 7.5% | ||
| Q1 25 | 22.4% | 12.5% | ||
| Q4 24 | 24.0% | 11.5% | ||
| Q3 24 | 21.1% | 2.0% | ||
| Q2 24 | 23.1% | 1.5% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 8.9% | ||
| Q3 25 | 19.3% | 14.1% | ||
| Q2 25 | 12.9% | 4.6% | ||
| Q1 25 | 18.9% | 8.8% | ||
| Q4 24 | 20.6% | 9.9% | ||
| Q3 24 | 17.9% | 1.4% | ||
| Q2 24 | 19.6% | 1.2% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.39 | ||
| Q3 25 | $1.18 | $0.55 | ||
| Q2 25 | $0.75 | $0.17 | ||
| Q1 25 | $1.11 | $0.34 | ||
| Q4 24 | $1.23 | $0.46 | ||
| Q3 24 | $0.97 | $0.05 | ||
| Q2 24 | $1.05 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $848.8M |
| Total DebtLower is stronger | $3.0B | $1.1B |
| Stockholders' EquityBook value | $6.9B | $2.3B |
| Total Assets | $12.8B | $6.8B |
| Debt / EquityLower = less leverage | 0.44× | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $848.8M | ||
| Q3 25 | $1.5B | $707.5M | ||
| Q2 25 | $1.5B | $736.7M | ||
| Q1 25 | $1.5B | $574.4M | ||
| Q4 24 | $1.3B | $690.0M | ||
| Q3 24 | $1.8B | $577.1M | ||
| Q2 24 | $1.7B | $641.4M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $1.1B | ||
| Q3 25 | $3.4B | $1.0B | ||
| Q2 25 | $3.3B | $1.0B | ||
| Q1 25 | $3.3B | $987.4M | ||
| Q4 24 | $3.3B | $994.0M | ||
| Q3 24 | $2.1B | $1.0B | ||
| Q2 24 | $2.1B | $1.0B |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $2.3B | ||
| Q3 25 | $6.4B | $2.2B | ||
| Q2 25 | $6.1B | $2.1B | ||
| Q1 25 | $6.0B | $2.0B | ||
| Q4 24 | $5.9B | $2.0B | ||
| Q3 24 | $5.9B | $1.9B | ||
| Q2 24 | $6.2B | $2.0B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $6.8B | ||
| Q3 25 | $12.2B | $6.7B | ||
| Q2 25 | $12.2B | $6.5B | ||
| Q1 25 | $11.9B | $6.2B | ||
| Q4 24 | $11.8B | $6.4B | ||
| Q3 24 | $11.0B | $6.3B | ||
| Q2 24 | $10.9B | $6.2B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.46× | ||
| Q3 25 | 0.53× | 0.48× | ||
| Q2 25 | 0.55× | 0.49× | ||
| Q1 25 | 0.56× | 0.49× | ||
| Q4 24 | 0.57× | 0.50× | ||
| Q3 24 | 0.36× | 0.54× | ||
| Q2 24 | 0.34× | 0.51× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $266.8M |
| Free Cash FlowOCF − Capex | $175.0M | $215.7M |
| FCF MarginFCF / Revenue | 9.7% | 12.2% |
| Capex IntensityCapex / Revenue | 5.2% | 2.9% |
| Cash ConversionOCF / Net Profit | 0.88× | 1.69× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $308.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $266.8M | ||
| Q3 25 | $362.0M | $24.8M | ||
| Q2 25 | $221.0M | $185.5M | ||
| Q1 25 | $431.0M | $52.5M | ||
| Q4 24 | $481.0M | $297.3M | ||
| Q3 24 | $452.0M | $52.3M | ||
| Q2 24 | $333.0M | $262.8M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $215.7M | ||
| Q3 25 | $259.0M | $-39.4M | ||
| Q2 25 | $107.0M | $146.0M | ||
| Q1 25 | $334.0M | $-14.1M | ||
| Q4 24 | $388.0M | $231.6M | ||
| Q3 24 | $360.0M | $2.3M | ||
| Q2 24 | $230.0M | $222.6M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 12.2% | ||
| Q3 25 | 14.9% | -2.6% | ||
| Q2 25 | 6.4% | 10.1% | ||
| Q1 25 | 19.9% | -0.9% | ||
| Q4 24 | 22.8% | 12.6% | ||
| Q3 24 | 22.8% | 0.2% | ||
| Q2 24 | 14.6% | 15.4% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 2.9% | ||
| Q3 25 | 5.9% | 4.2% | ||
| Q2 25 | 6.8% | 2.7% | ||
| Q1 25 | 5.8% | 4.4% | ||
| Q4 24 | 5.5% | 3.6% | ||
| Q3 24 | 5.8% | 3.3% | ||
| Q2 24 | 6.5% | 2.8% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.69× | ||
| Q3 25 | 1.08× | 0.11× | ||
| Q2 25 | 1.03× | 2.77× | ||
| Q1 25 | 1.36× | 0.39× | ||
| Q4 24 | 1.37× | 1.63× | ||
| Q3 24 | 1.60× | 2.53× | ||
| Q2 24 | 1.08× | 14.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
LEVI
| Other | $760.3M | 43% |
| Sales Channel Through Intermediary | $583.2M | 33% |
| Sales Channel Directly To Consumer | $376.0M | 21% |
| Beyond Yoga | $46.3M | 3% |
